Login to Your Account

Washington Roundup

NIAID Cancels HIV Vaccine Trial, but Adds More Focused One

By Donna Young

Monday, July 21, 2008
WASHINGTON - The National Institute of Allergy and Infectious Diseases (NIAID) has scrapped a large-scale HIV vaccine study, known as PAVE 100, and has opted instead to conduct a smaller, more focused trial of the agency's investigational vaccine. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription